Core Viewpoint - The recent performance of Da Health International (02211) indicates significant declines in revenue and profit, attributed to changes in China's healthcare policies and a decrease in active customers within its national distribution network [1] Financial Performance - For the fiscal year ending June 30, 2025, Da Health International reported revenues of approximately HKD 711.5 million, a year-on-year decrease of 34.7% [1] - The gross profit was around HKD 113.4 million, reflecting a 37% decline compared to the previous year [1] - The company recorded a loss attributable to shareholders of HKD 26.06 million, marking a shift from profit to loss year-on-year [1] - The loss per share was reported at HKD 0.3246 [1] Shareholder Activity - On January 28, shareholders transferred shares from Futu Securities International Hong Kong to Baoxin Securities, with a transfer value of HKD 30.35 million, representing 5.48% of the company's market capitalization [1]
大健康国际股东将股票由富途证券国际香港转入宝新证券 转仓市值3035.37万港元